Physician

Brent A Flickinger, MD

According to 2025 Medicare claims, Brent Flickinger, MD (NPI: 1902914872) practices rheumatology in the Gainesville, GA market, with the plurality of this provider's patient population coming from Hall, GA. This provider's primary affiliated billing organization is SOUTHEASTERN RHEUMATOLOGY ALLIANCE (NPI: 1114795663; TIN: 933460719) and primary practice location at 30501-2403. Flickinger is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Flickinger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 729 traditional Medicare patients, billed 191,321 HCPCS/CPT codes, and received $2,315,567 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,477 prescription claims across 780 beneficiaries totaling $5,623,570 in drug costs, led by Orencia Clickject (Abatacept). 2018 DME data shows 12 claims. Open Payments data shows 217 records totaling $936,796. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	697	117,463	$2,347,979
2016	762	158,137	$2,920,462
2017	947	178,991	$3,385,546
2018	1,015	184,872	$3,450,595
2019	914	194,720	$3,179,624
2020	764	171,366	$2,986,367
2021	758	213,405	$3,087,010
2022	741	212,305	$2,667,199
2023	752	194,086	$2,321,227
2024	729	191,321	$2,315,567

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	707	7,436	$3,171,321
2016	781	7,899	$3,708,074
2017	810	7,622	$3,898,452
2018	771	5,786	$3,191,591
2019	740	5,331	$3,435,099
2020	715	5,720	$4,018,058
2021	730	4,816	$3,232,159
2022	715	4,574	$2,923,614
2023	714	4,240	$3,281,615
2024	780	5,477	$5,623,570

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	14	$2,008
2018	N/R	12	$962
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	422	821	$89
80053	Blood test, comprehensive group of blood chemicals	318	437	$10
36415	Insertion of needle into vein for collection of blood sample	422	836	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	306	424	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	240	318	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orencia Clickject	Abatacept	107	3,276	$690,057
Enbrel Sureclick	Etanercept	67	2,268	$575,920
Humira(Cf) Pen	Adalimumab	61	2,062	$550,104
Arcalyst	Rilonacept	16	448	$374,689
Humira(Cf)	Adalimumab	21	896	$287,646

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	210	$4,048	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	7	$932,748	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brent A. Flickinger, MD?

Tedicare shows public-source Medicare data for Brent A. Flickinger, MD (NPI 1902914872), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brent A. Flickinger, MD have ACO affiliation data?

Brent A. Flickinger, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to Brent A. Flickinger, MD?

Brent A. Flickinger, MD is linked to SOUTHEASTERN RHEUMATOLOGY ALLIANCE (billing NPI 1114795663) in the available physician profile data.

Does Brent A. Flickinger, MD have Open Payments data?

Brent A. Flickinger, MD has 217 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.